当前位置:首页 - 行情中心 - 康弘药业(002773) - 财务分析

康弘药业

(002773)

  

流通市值:154.39亿  总市值:207.11亿
流通股本:6.87亿   总股本:9.21亿

康弘药业(002773)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润3.03亿元,每股收益0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益957812.50万元,未分配利润614060.41万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1020952.13万元,负债63139.63万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,046,478,561.324,585,133,789.583,623,865,721.062,453,661,937.96
营业总成本690,570,560.843,278,743,141.862,438,543,787.091,619,188,513.48
其他经营收益
营业利润359,268,864.951,377,365,453.561,228,093,544.11864,603,231.25
利润总额358,511,883.121,356,113,549.831,208,450,737.95852,462,294.74
净利润303,203,363.731,145,503,613.711,021,124,394.93721,864,033.83
每股收益
其他综合收益273,714.13-126,281.75-322,319.27-64,852.09
综合收益总额303,477,077.861,145,377,331.961,020,802,075.66721,799,181.74
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计7,439,323,596.847,084,460,574.887,023,154,380.286,632,270,664.09
非流动资产:
非流动资产合计2,770,197,721.232,835,404,169.792,846,879,479.342,900,466,376.23
资产总计10,209,521,318.079,919,864,744.679,870,033,859.629,532,737,040.32
流动负债:
流动负债合计585,929,930.42601,716,725.88678,189,594.14646,420,489.64
非流动负债:
非流动负债合计45,466,403.9443,500,112.9441,790,466.3337,248,375.33
负债合计631,396,334.36645,216,838.82719,980,060.47683,668,864.97
所有者权益(或股东权益):
归属于母公司股东权益合计9,606,672,334.719,298,916,486.149,166,361,0198,862,968,325.24
股东权益合计9,578,124,983.719,274,647,905.859,150,053,799.158,849,068,175.35
负债和股东权益合计10,209,521,318.079,919,864,744.679,870,033,859.629,532,737,040.32
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,192,884,200.575,096,077,203.773,986,339,017.662,648,154,933.64
经营活动现金流出小计848,573,489.193,592,428,751.052,578,063,329.641,732,368,612.54
经营活动产生的现金流量净额344,310,711.381,503,648,452.721,408,275,688.02915,786,321.1
投资活动产生的现金流量:
投资活动现金流入小计27,567.615,993,368,067.743,252,470,799.992,649,006,743.42
投资活动现金流出小计509,754,905.956,218,734,608.585,985,103,898.115,379,725,030.49
投资活动产生的现金流量净额-509,727,338.34-225,366,540.84-2,732,633,098.12-2,730,718,287.07
筹资活动产生的现金流量:
筹资活动现金流入小计-35,067,48535,047,48529,342,742.5
筹资活动现金流出小计1,267,868.41554,590,178.97554,159,752.76554,290,982.55
筹资活动产生的现金流量净额-1,267,868.41-519,522,693.97-519,112,267.76-524,948,240.05
汇率变动对现金及现金等价物的影响-157,509.87-482,965.57-551,595.52-2,359.72
现金及现金等价物净增加额-166,842,005.24758,276,252.34-1,844,021,273.38-2,339,882,565.74
期末现金及现金等价物余额6,216,861,493.666,383,703,498.93,781,405,973.183,285,544,680.82
补充资料:
现金及现金等价物的净增加额-758,276,252.34--2,339,882,565.74
最新报告期:2026-04-28
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
信达证券唐爱金1.371.501.682026-04-28
TOP↑